BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 30941138)

  • 1. What Are the Peripheral Blood Determinants for Increased Osteoclast Formation in the Various Inflammatory Diseases Associated With Bone Loss?
    de Vries TJ; El Bakkali I; Kamradt T; Schett G; Jansen IDC; D'Amelio P
    Front Immunol; 2019; 10():505. PubMed ID: 30941138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal Inflammation Promotes MDL-1
    Peek CT; Ford CA; Eichelberger KR; Jacobse J; Torres TP; Maseda D; Latour YL; Piazuelo MB; Johnson JR; Byndloss MX; Wilson KT; Rathmell JC; Goettel JA; Cassat JE
    Cell Mol Gastroenterol Hepatol; 2022; 14(4):731-750. PubMed ID: 35835390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
    Michael H; Härkönen PL; Väänänen HK; Hentunen TA
    J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoclast precursor interaction with bone matrix induces osteoclast formation directly by an interleukin-1-mediated autocrine mechanism.
    Yao Z; Xing L; Qin C; Schwarz EM; Boyce BF
    J Biol Chem; 2008 Apr; 283(15):9917-24. PubMed ID: 18250170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The polymethoxy flavonoid sudachitin suppresses inflammatory bone destruction by directly inhibiting osteoclastogenesis due to reduced ROS production and MAPK activation in osteoclast precursors.
    Ohyama Y; Ito J; Kitano VJ; Shimada J; Hakeda Y
    PLoS One; 2018; 13(1):e0191192. PubMed ID: 29342179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different Blood-Borne Human Osteoclast Precursors Respond in Distinct Ways to IL-17A.
    Sprangers S; Schoenmaker T; Cao Y; Everts V; de Vries TJ
    J Cell Physiol; 2016 Jun; 231(6):1249-60. PubMed ID: 26491867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased osteoclast formation and activity by peripheral blood mononuclear cells in chronic liver disease patients with osteopenia.
    Olivier BJ; Schoenmaker T; Mebius RE; Everts V; Mulder CJ; van Nieuwkerk KM; de Vries TJ; van der Merwe SW
    Hepatology; 2008 Jan; 47(1):259-67. PubMed ID: 18022900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of osteoclast differentiation and collagen antibody-induced arthritis by CTHRC1.
    Jin YR; Stohn JP; Wang Q; Nagano K; Baron R; Bouxsein ML; Rosen CJ; Adarichev VA; Lindner V
    Bone; 2017 Apr; 97():153-167. PubMed ID: 28115279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokine signals are crucial for enhanced homing and differentiation of circulating osteoclast progenitor cells.
    Sucur A; Jajic Z; Artukovic M; Matijasevic MI; Anic B; Flegar D; Markotic A; Kelava T; Ivcevic S; Kovacic N; Katavic V; Grcevic D
    Arthritis Res Ther; 2017 Jun; 19(1):142. PubMed ID: 28619088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of osteoclast progenitors in inflammatory conditions: key to bone destruction in arthritis.
    Sućur A; Katavić V; Kelava T; Jajić Z; Kovačić N; Grčević D
    Int Orthop; 2014 Sep; 38(9):1893-903. PubMed ID: 24913769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of particle-induced osteolysis by interleukin-6 involves anti-inflammatory effect and inhibition of early osteoclast precursor differentiation.
    Darowish M; Rahman R; Li P; Bukata SV; Gelinas J; Huang W; Flick LM; Schwarz EM; O'Keefe RJ
    Bone; 2009 Oct; 45(4):661-8. PubMed ID: 19524707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The increased in vitro osteoclastogenesis in patients with rheumatoid arthritis is due to increased percentage of precursors and decreased apoptosis - the In Vitro Osteoclast Differentiation in Arthritis (IODA) study.
    Durand M; Boire G; Komarova SV; Dixon SJ; Sims SM; Harrison RE; Nabavi N; Maria O; Manolson MF; Mizianty M; Kurgan L; de Brum-Fernandes AJ
    Bone; 2011 Mar; 48(3):588-96. PubMed ID: 20959150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNF Induction of NF-κB RelB Enhances RANKL-Induced Osteoclastogenesis by Promoting Inflammatory Macrophage Differentiation but also Limits It through Suppression of NFATc1 Expression.
    Zhao Z; Hou X; Yin X; Li Y; Duan R; Boyce BF; Yao Z
    PLoS One; 2015; 10(8):e0135728. PubMed ID: 26287732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation induces osteoclast differentiation from peripheral mononuclear cells in chronic kidney disease patients: crosstalk between the immune and bone systems.
    Cafiero C; Gigante M; Brunetti G; Simone S; Chaoul N; Oranger A; Ranieri E; Colucci S; Pertosa GB; Grano M; Gesualdo L
    Nephrol Dial Transplant; 2018 Jan; 33(1):65-75. PubMed ID: 28992140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Osteoclastogenesis and Bone Resorption in vitro and in vivo by a prenylflavonoid xanthohumol from hops.
    Li J; Zeng L; Xie J; Yue Z; Deng H; Ma X; Zheng C; Wu X; Luo J; Liu M
    Sci Rep; 2015 Dec; 5():17605. PubMed ID: 26620037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of hematopoietic cell kinase ameliorates the bone destruction associated with inflammation.
    Kim Y; Hayashi M; Ono T; Yoda T; Takayanagi H; Nakashima T
    Mod Rheumatol; 2020 Jan; 30(1):85-92. PubMed ID: 30486712
    [No Abstract]   [Full Text] [Related]  

  • 18. Osteoclastogenesis and arthritis.
    Maruotti N; Grano M; Colucci S; d'Onofrio F; Cantatore FP
    Clin Exp Med; 2011 Sep; 11(3):137-45. PubMed ID: 21069419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Licorice isoliquiritigenin suppresses RANKL-induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo.
    Zhu L; Wei H; Wu Y; Yang S; Xiao L; Zhang J; Peng B
    Int J Biochem Cell Biol; 2012 Jul; 44(7):1139-52. PubMed ID: 22521613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RARγ is a negative regulator of osteoclastogenesis.
    Green AC; Poulton IJ; Vrahnas C; Häusler KD; Walkley CR; Wu JY; Martin TJ; Gillespie MT; Chandraratna RA; Quinn JM; Sims NA; Purton LE
    J Steroid Biochem Mol Biol; 2015 Jun; 150():46-53. PubMed ID: 25800721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.